Showing 5,041 - 5,060 results of 60,573 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((a decrease) OR (mean decrease)) ))', query time: 0.72s Refine Results
  1. 5041
  2. 5042
  3. 5043

    Transferrin Receptor-Mediated Cellular Uptake of Fluorinated Chlorido[<i>N</i>,<i>N</i>′‑bis(salicylidene)-1,2-phenylenediamine]iron(III) Complexes by Astrid Dagmar Bernkop-Schnürch (17461895)

    Published 2024
    “…All complexes significantly decreased the metabolic activity in the tested ovarian cancer (A2780, A2780cis), breast cancer (MDA-MB 231), and leukemia (HL-60) cell lines, while the nonmalignant human stroma cell line HS-5 at a concentration of 0.5 μM, which represents the IC<sub>50</sub> of the complexes in most of the used tumorigenic cell lines, was not affected. …”
  4. 5044
  5. 5045
  6. 5046
  7. 5047
  8. 5048
  9. 5049
  10. 5050
  11. 5051
  12. 5052

    Reply to Jüni and colleagues regarding “Converting standardized mean differences to dichotomous outcomes: A comment on the Cochrane review ‘Intra-articular corticosteroid for knee... by Martin Mayer (6509486)

    Published 2019
    “…Converting standardized mean differences to dichotomous outcomes: A comment on the Cochrane review ‘Intra-articular corticosteroid for knee osteoarthritis’. …”
  13. 5053
  14. 5054
  15. 5055
  16. 5056
  17. 5057

    Image_5_Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.pdf by Mudit Chowdhary (6016496)

    Published 2019
    “…On multivariate logistic analysis, the following factors were found to be significant for receipt of PRT (all p < 0.05): academic facility (odds ratio [OR] = 2.50), South (OR = 2.01) and West location (OR = 12.43), left-sided (OR = 1.21), ER-positive (OR = 1.59), and mastectomy (OR = 1.47); pT2-T4 disease predicted for decrease use (OR = 0.79). …”
  18. 5058
  19. 5059
  20. 5060